SG Americas Securities LLC Buys 27,204 Shares of Cerus Co. (NASDAQ:CERS)

Share on StockTwits

SG Americas Securities LLC lifted its stake in Cerus Co. (NASDAQ:CERS) by 27.4% during the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 126,436 shares of the biotechnology company’s stock after buying an additional 27,204 shares during the quarter. SG Americas Securities LLC owned about 0.08% of Cerus worth $834,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds and other institutional investors also recently bought and sold shares of the company. Ameritas Investment Partners Inc. grew its holdings in Cerus by 16.9% during the 1st quarter. Ameritas Investment Partners Inc. now owns 12,550 shares of the biotechnology company’s stock valued at $58,000 after buying an additional 1,812 shares in the last quarter. SeaCrest Wealth Management LLC boosted its holdings in shares of Cerus by 9.7% in the 1st quarter. SeaCrest Wealth Management LLC now owns 22,600 shares of the biotechnology company’s stock worth $105,000 after purchasing an additional 2,000 shares during the period. Envestnet Asset Management Inc. boosted its holdings in shares of Cerus by 6.8% in the 1st quarter. Envestnet Asset Management Inc. now owns 32,848 shares of the biotechnology company’s stock worth $153,000 after purchasing an additional 2,094 shares during the period. Principal Financial Group Inc. boosted its holdings in shares of Cerus by 6.0% in the 1st quarter. Principal Financial Group Inc. now owns 42,750 shares of the biotechnology company’s stock worth $199,000 after purchasing an additional 2,434 shares during the period. Finally, Partnervest Advisory Services LLC boosted its holdings in shares of Cerus by 13.2% in the 1st quarter. Partnervest Advisory Services LLC now owns 25,683 shares of the biotechnology company’s stock worth $119,000 after purchasing an additional 3,000 shares during the period. 80.07% of the stock is currently owned by hedge funds and other institutional investors.

Shares of CERS stock opened at $7.13 on Friday. Cerus Co. has a 52-week low of $2.71 and a 52-week high of $7.49. The company has a debt-to-equity ratio of 0.51, a quick ratio of 3.47 and a current ratio of 3.95. The firm has a market capitalization of $1.17 billion, a P/E ratio of -14.85 and a beta of 1.29. The stock has a 50 day moving average price of $6.64 and a 200 day moving average price of $5.41.

Cerus (NASDAQ:CERS) last issued its quarterly earnings results on Tuesday, May 5th. The biotechnology company reported ($0.10) earnings per share (EPS) for the quarter, hitting the Zacks’ consensus estimate of ($0.10). The firm had revenue of $18.61 million during the quarter, compared to analyst estimates of $17.60 million. Cerus had a negative return on equity of 93.16% and a negative net margin of 90.97%. As a group, sell-side analysts forecast that Cerus Co. will post -0.42 EPS for the current year.

A number of equities analysts have recently commented on CERS shares. Zacks Investment Research cut Cerus from a “buy” rating to a “hold” rating in a report on Thursday, June 18th. Stifel Nicolaus lifted their target price on Cerus from $7.00 to $8.00 and gave the stock a “buy” rating in a report on Wednesday, May 27th. BidaskClub cut Cerus from a “buy” rating to a “hold” rating in a report on Saturday, July 11th. Cantor Fitzgerald initiated coverage on Cerus in a research note on Monday, June 15th. They set a “buy” rating and a $9.00 price target for the company. Finally, Stephens decreased their price target on Cerus from $7.50 to $6.50 and set an “overweight” rating for the company in a research note on Thursday, April 16th. Three investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. Cerus has a consensus rating of “Buy” and an average price target of $7.40.

In other Cerus news, insider Chrystal Menard sold 20,351 shares of Cerus stock in a transaction on Tuesday, May 12th. The stock was sold at an average price of $5.67, for a total transaction of $115,390.17. Following the completion of the sale, the insider now directly owns 72,206 shares of the company’s stock, valued at approximately $409,408.02. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, SVP Carol Moore sold 130,000 shares of Cerus stock in a transaction on Thursday, June 25th. The shares were sold at an average price of $7.00, for a total value of $910,000.00. Following the sale, the senior vice president now directly owns 241,751 shares of the company’s stock, valued at $1,692,257. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 334,959 shares of company stock valued at $2,333,550. 7.26% of the stock is currently owned by corporate insiders.

Cerus Company Profile

Cerus Corporation, a biomedical products company, focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended for transfusion.

Recommended Story: Coverage Ratio

Institutional Ownership by Quarter for Cerus (NASDAQ:CERS)

Receive News & Ratings for Cerus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cerus and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Assenagon Asset Management S.A. Buys New Shares in Legg Mason Inc
Assenagon Asset Management S.A. Buys New Shares in Legg Mason Inc
10,391 Shares in Territorial Bancorp Inc  Acquired by Assenagon Asset Management S.A.
10,391 Shares in Territorial Bancorp Inc Acquired by Assenagon Asset Management S.A.
Assenagon Asset Management S.A. Acquires Shares of 79,479 RTI Surgical Holdings Inc
Assenagon Asset Management S.A. Acquires Shares of 79,479 RTI Surgical Holdings Inc
Assenagon Asset Management S.A. Takes $256,000 Position in Bel Fuse, Inc.
Assenagon Asset Management S.A. Takes $256,000 Position in Bel Fuse, Inc.
Assenagon Asset Management S.A. Has $261,000 Position in Resolute Forest Products
Assenagon Asset Management S.A. Has $261,000 Position in Resolute Forest Products
Assenagon Asset Management S.A. Takes $270,000 Position in World Fuel Services Corp
Assenagon Asset Management S.A. Takes $270,000 Position in World Fuel Services Corp


© 2006-2020 Ticker Report